当前位置:首页 - 行情中心 - 成大生物(688739) - 财务分析 - 现金流量表

成大生物

(688739)

  

流通市值:110.44亿  总市值:110.44亿
流通股本:4.16亿   总股本:4.16亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,012,333,409.43657,961,769.62306,402,043.441,720,563,262.48
  收到的税费返还554,299.08780,714.19780,714.19722,037.1
  收到其他与经营活动有关的现金32,031,729.7424,556,465.5312,681,226.6356,365,430.96
  经营活动现金流入小计1,044,919,438.25683,298,949.34319,863,984.261,777,650,730.54
  购买商品、接受劳务支付的现金214,480,984.36121,092,610.3545,091,863.47299,316,629.39
  支付给职工以及为职工支付的现金280,110,219.89208,200,900.16137,474,832.93345,973,182.35
  支付的各项税费89,859,118.1443,715,463.3914,658,153.37178,169,372.99
  支付其他与经营活动有关的现金289,451,134.88183,809,029.8584,143,585.54453,232,119.45
  经营活动现金流出小计873,901,457.27556,818,003.75281,368,435.311,276,691,304.18
  经营活动产生的现金流量净额171,017,980.98126,480,945.5938,495,548.95500,959,426.36
二、投资活动产生的现金流量:
  收回投资收到的现金3,504,395,334.712,329,320,000759,000,0004,889,178,236.9
  取得投资收益收到的现金22,040,132.614,136,8114,645,263.127,197,078.36
  处置固定资产、无形资产和其他长期资产收回的现金净额3,500--10,982,149.82
  收到的其他与投资活动有关的现金---5,000,000
  投资活动现金流入小计3,526,438,967.312,343,456,811763,645,263.14,932,357,465.08
  购建固定资产、无形资产和其他长期资产支付的现金251,993,518.47182,317,662.1478,107,021.81362,483,478.94
  投资支付的现金3,589,000,0002,799,000,0001,259,000,0004,732,370,620
  支付其他与投资活动有关的现金344,000.62264,510.84250,016.78333,061.38
  投资活动现金流出小计3,841,337,519.092,981,582,172.981,337,357,038.595,095,187,160.32
  投资活动产生的现金流量净额-314,898,551.78-638,125,361.98-573,711,775.49-162,829,695.24
三、筹资活动产生的现金流量:
  分配股利、利润或偿付利息支付的现金329,224,279.84329,224,279.84-329,381,580.8
  支付其他与筹资活动有关的现金14,264,291.733,034,254.62611,036.0555,850,433.01
  筹资活动现金流出小计343,488,571.57332,258,534.46611,036.05385,232,013.81
  筹资活动产生的现金流量净额-343,488,571.57-332,258,534.46-611,036.05-385,232,013.81
四、汇率变动对现金及现金等价物的影响970,746.96980,417.67460,866.88548,387.95
五、现金及现金等价物净增加额-486,398,395.41-842,922,533.18-535,366,395.71-46,553,894.74
  加:期初现金及现金等价物余额4,498,051,446.794,498,051,446.794,498,051,446.794,544,605,341.53
  期末现金及现金等价物余额4,011,653,051.383,655,128,913.613,962,685,051.084,498,051,446.79
补充资料:
  净利润-122,294,675.25-342,821,554.27
  资产减值准备-16,369,205.15-75,387,882.53
  固定资产和投资性房地产折旧-79,264,838.3-160,808,964.68
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-79,264,838.3-160,808,964.68
  无形资产摊销-3,572,592.27-6,701,294.62
  长期待摊费用摊销-2,069,128.26-3,810,695.97
  处置固定资产、无形资产和其他长期资产的损失----88,290.32
  固定资产报废损失-278,061.06-1,803,639.74
  公允价值变动损失-2,669,752.62-33,421,748.59
  财务费用--650,644.23-286,024.6
  投资损失--13,267,031.43--15,549,868.15
  递延所得税--11,743,323.95--2,627,466.06
  其中:递延所得税资产减少--11,639,468.05-6,674,461.58
    递延所得税负债增加--103,855.9--9,301,927.64
  存货的减少--16,577,383.02--73,274,232.69
  经营性应收项目的减少--71,066,385.17--18,023,812.39
  经营性应付项目的增加--5,495,052.05--27,587,415.83
  其他-32,466.84-55,417.38
  现金的期末余额-3,655,128,913.61-4,498,051,446.79
  减:现金的期初余额-4,498,051,446.79-4,544,605,341.53
  现金及现金等价物的净增加额--842,922,533.18--46,553,894.74
公告日期2025-10-302025-08-292025-04-302025-04-24
审计意见(境内)标准无保留意见
TOP↑